Medtronic stories

In 2021, Medtronic stopped distributing the HVADs following studies that showed recipients had a higher risk of suffering strokes than those who were implanted with another company’s VAD. But Medtronic’s mission didn’t end with the suspension. In this episode, Raj Thomas, vice president and general manager of MCS, explains how his team continues to support recipients, their caregivers and clinicians to help ensure those heart failure patients can live the fullest lives possible.

Medtronic strategically partners with other organizations that share a commitment to removing barriers to equity

Tim Berry battled addiction for years. Could a heart condition rob him of the healthy life he had worked so hard to build?

Medtronic LABS bridges hyper-local solutions with cutting-edge tech

Know the signs of severe illness